Breast Surgery Flashcards
Wha is the Breast Triple Assessment?
Suggest 2 critertia for referral by GP
A hospital-based assessment clinic, allowing early+rapid detection of breast cancer
- Signs/symptoms that meet the breast cancer 2ww referral criteria
- Suspicious finding on routine screening
Outline the Breast Triple Assessment stages
- History (PC, RFs, FHx, Dx, PMHx, Sx etc) + Exam
- Imaging
- Biopsy
Outling the Imaging stage of the Breast Triple Assessment
(MRI can be useful in assessing lobular breast cancers + response to neoadjuvant therapy. Whilst it has high sensitivity, it has a low specificity)
Mammography (can be done w/ Contrast)
- Compression views of breast across 2 views
- Allows to detect Mass Lesions or Micro-calcifications
USS;
- More useful in Women <35 and Men (due to tissue density)
- Also routiney used during core biopsies
Outline the Biopsy/ Histoloy stage of the Breast Triple Assessment
(Required of any suspicious mass/ lesion presenting to the clinic, most commonly via core biopsy)
Core Biopsy;
- Provides histology, allowing differentiation between Invasive and In-situ Carcinoma
- Higher Sensitvity + Specifcity than FNA
FNA Biopsy; (Fine needle aspiration)
- Provides Cytology
- Used if Recurrent Cystic disease, to relieve symptoms
Malignancy suspicion is graded at each stage
Outline how an Overall Risk Index is created by Triple Assessment, to determine if;
- Benign/ Malignant
- Further intervention+biopsy needed
P= Examination Score, B= Histology score
Imaging (Mammography/ USS) Score= M/U
1= Normal 2= Benign 3= Uncertain/ Likely Benign 4= Suspicious of Malignancy 5= Malignant
What is a common way to categorise types of Breast Pain
- Cyclical (most common)
- Non-cylical
- Extra Mammary (E.g Chest wall/ Shoulder pain)
Outline Cyclical Breast Pain
- Pain assosciated with Menstrual cycle
- Begins few days before beginning and subsiding at end
- Typically, affects both breasts
- Mostly in those activlely Menstruating or using HRT
Outline Non-Cyclical Breast Pain
33% of Breast pain cases
Can be caused by Medications, e.g;
- Hormonal contraceptives
- Anti-depressants (Sertraline)
- Anti-psychotics (Haloperidol)
What features do you ask about in a pt with Mastalgia
Lumps, Skin changes, Discharge, Fevers
Assosciation with menstrual cycle
Pregnancies, Breast-feeding
Dx, PMHx, Fx
Outline Investigations for Breast pain
Mastalgia alone does not qualify for Imaging
All pts within reproductive age should have a Pregnancy test
Outline Breast pain managment
Most cases are Idiopathic
1st: Reassurance + Pain control;
- Better fitting or Soft support bra during night
- Oral Ibuprofen/ Paracetamol or Topical NSAIDs
2nd: Refer to specalist;
- Consider Danazol (Anti-Gonadotrophin agent)
- ADRs: Nausea, Dizziness, Weight gain
What is Galactorrhoea
Copious, Bilateral, Multi-ductal, Milky discharge not assosciated with Pregnancy or Lactation
(Includes Milk production 6-12mths after pregnancy and cessation of breast-feeding)
Dopamine acts to inhibit PRL secretion, which is the main hormone regulating Lactation
Outline the effects of TRH and Oestrogen on Prolactin secretion from Ant Pit gland
Both increases PRL secretion
Hyperprolactinaemia is the most commn cause of Galactorrhoea
List causes of Hyper-PRL
- Idiopathic: 40% of cases
- Pituitary Adenoma
- Drugs: SSRIs, Anti-psychotics, H2 Antagonists
- Neurological: Dopamine inhibited (VZ infection)
- HypoTism: Elevated TRH
- Renal/ Liver failure
- Pituitary Stalk damage: Reduced inhibition from Dopamine
Normoprolactinaemic galactorrhoea is less common and is typically idiopathic, the diagnosis only being made once all other causes of galactorrhoea have been excluded (i.e. normal blood markers and regular menstruation).
How are these pts treated
These patients can often safely be reassured and observed
What features do you ask about in a pt with Galactorrhoea
Important to confirm True Galactorrhoea
Lumps, Mastalgia, LMP
Features of Endocrine disease Neurological symptoms (Headache, Vision changes)
Dx very important
Outline Investigations for Galactorrhoea
Pregnancy test if reproductive age
- TFTs, LFTs, U&Es
- Serum PRL (>1000mU/L suggests Prolactinoma)
MRI w/ Contrast: If Pituitary tumour suspected
Breast imaging: Consider if Palpable Lumps/ L Nodes
Outline Galactorrhoea management
Confirmed Pituitary tumours;
- Dopamine Agonist therapy (Cabergoline, Bromocriptine)
- Potentially, Trans-Sphenoidal surgery
Idiopathic Normoprolactinaemic;
- Resolves on its own
- If persistent, can trial Dopamine agonist therapy
Troublesome Galactorrhoea + Medication intolerance;
- Bilateral Total Duct Excision
Carcinomas in situ are malignancies that contained within BM tissue. They are seen as pre-malignant condition, typically found on imaging and are asymptomatic
What are the 2 main types in Breast disease
- DCIS, Ductal Carcinoma In Situ
- LCIS, Lobular Carcinoma In Situ
DCIS is themost common non-invasive breast malignancy. It represents 20% of all diagnosed breast cancers
Describe it and its Prognosis
Malignancy of Ductal tissue of beast, contained within the BM
Left untreated, 20-30% will develop invasive disease
Outline Investigations for/ Diagosis of DCIS
Often detected during screening;
- Appears as Microcalcifications on Mammography
- Either Localised OR Wide-spread
This is confirmed on Biopsy
List the Subtypes of DCIS and compare their most likely apperance on Mammography
(Most lesions are mixed)
Comedo- Microcalcifications
Cribriform- Multi-focal
Micropapillary- Multi-focal
Solid- Multi-focal
Outline DCIS Management
Localised DCIS;
- Complete wide excision
- Ensure surroundng tissue of all magins have no residual disease
Cases of Widespread or Multifocal DCIS;
- Usually, Complete Mastectomy
Describe LCIS
Compare it to DCIS
Malignancy of the Secretory lobules of the breast, contained within BM
Compared to DCIS, LCIS is;
- Rarer
- More at risk of developing Invasive malignancy
Outline Diagnosis of LCIS
Usually diagnosed;
- Before Menopause (>90%)
- Incidentally during Biopsy
Outline LCIS Managment
Low grade LCIS;
- Monitoring rather than Excision
If pt has BRCA1/2 genes;
- Consider Bilateral Prophylactic Mastectomy
How do Breast Carcinomas-in-situ usually present?
Usually Asymptomatic, found incidentally/ by screening
Carcinoma of the breast is the most common cancer in the Western world and accounts for 20% of all cancers in women in the UK, with 1 in 10 women developing breast cancer in their lifetime
List the classes of Invasive Breast Carcinoma
- IDC, Invasive Ductal Carcinoma (75-85%)
- ILC, Invasive Lobular Carcinoma (10%)
Others (5%)
- E.g Medullar or Colloid Carcinoma
Why is the division of Breast carcinomas into Ductal and Lobular WRONG?
Why is it still used as a classification
Almost all breast carcinomas arise in the Terminal Duct Lobular Unit
The 2 subtypes behave differently
IDCs are the most common breast carcinomas (80% of all cases)
List their further classifications
Which 3 are Well-circumscribed and show the best Prognoses?
Further subtypes of IDCs;
- Tubular*
- Cribriform*
- Papillary*
- Mucinous/ Colloid
- Medullary
ILCs are;
- The 2nd most comon type of breast cancer (10% of all invasive cancers)
- More common in older women
Describe them
Characterised by diffuse/ stromal pattern of spread, that makes detection harder (hence by diagnosis, tumors are quite large)
List RFs for Invasive Breast Cancer
Similar to Breast Carcinomas In-Situ
2 Most significant RFs;
- Female sex
- Age (risk doubles every 10yrs until menopause)
- Gene mutations, Previous Benign disease
- Obesity, Alcohol, Geographic variation
- High exposure to unopposed Oestrogen
- Fx in 1st degree relative
List examples of High exposure to unopposed Oestrogen
- Early menarche
- Late menopause
- No children
- Oral contraceptive
- 1st pregnancy after 30y/o
- HRT use
How can Invasive Breast Cancer present
Can be Symptomatic or Asymptomatic
- Breast pain, Breast lump
- Palpable axilla lump
- Asymmetry, Skin changes (Paget’s, Dimpling)
- Swelling (all or part of breast)
- Nipples: Retraction, Abnormal discharge
Outline Investigations for Invasive Breast Cancer
Managment is Extensive+Variable
Gold standard: Triple Assessment